Several differentially expressed mRNAs in HER2-positive breast cancer (including CXCL2, CXCL12, CXCL10, CXCL11, CXCL9 and CXCL14) were enriched in the biology processes of chemokine receptor binding and chemokine activity. Here, CXCL9 is linked to breast carcinoma.